Evidence map›Paper›PMID 31390794›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Interaction of Gold Nanorods with Human Dermal Fibroblasts: Cytotoxicity, Cellular Uptake, and Wound Healing.

Nouf N Mahmoud, Lubna M Al-Kharabsheh, Enam A Khalil, Rana Abu-Dahab

Erratum issuedAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Dual-action of thermoresponsive gels containing DsiRNA-loaded gold nanoparticles for diabetic wound therapy: Characterization,Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Nouf N MahmoudFaculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan. nouf.mahmoud@zuj.edu.jo.ORCID 0000-0002-3870-7568
Lubna M Al-KharabshehSchool of Pharmacy, The University of Jordan, Amman 11942, Jordan.
Enam A KhalilSchool of Pharmacy, The University of Jordan, Amman 11942, Jordan. ekayoub@ju.edu.jo.ORCID 0000-0002-5878-443X
Rana Abu-DahabSchool of Pharmacy, The University of Jordan, Amman 11942, Jordan.ORCID 0000-0003-0857-7616

Funding

Deanship of Academic Research, University of Jordan 2017/2018/3/43Deanship of Scientific Research and Graduate Studies at Al-Zaytoonah University of Jordan 2017-2016/64/04
6 · The paper itself

Abstract

Herein, the cytotoxicity, cellular uptake and wound healing of human dermal fibroblasts were investigated upon treatment with gold nanorods (GNR) decorated with different ligands. Neutral and cationic poly ethylene glycol (PEG)-decorated GNR demonstrated the least cytotoxicity and cellular internalization, while anionic- and bovine serum albumin (BSA)-coated GNR revealed significant cytotoxicity and cellular uptake into human dermal fibroblasts. The cell scratch test demonstrated that neutral, cationic PEGylated GNR and anionic-decorated GNR have accelerated the wound healing rate in vitro after 24 h of incubation with scratched human dermal fibroblasts compared to control, while there was a drastic retardation of wound healing rate of scratched fibroblasts upon exposure to BSA-GNR accompanied with a significant release of the inflammatory cytokine; interlukin-1β (IL-1β). The cytotoxicity of GNR against the dermal cells and their ability to enhance the wound healing in vitro are greatly linked to their surface modifications.

Indexed as

cellular uptakecytotoxicitygold nanorodshuman dermal fibroblastsinterlukin-1βwound healing

Identifiers

PMID31390794
PMCPMC6722545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.